SCHEMBL8086452

SCHEMBL8086452

CCCCC(=S)N(SCC)SCC

nearest known ligand 0.35

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
ALDH2 P05091 1/20 0.35
CES1 P23141 2/20 0.33
CES2 O00748 1/20 0.33
MGLL Q99685 1/20 0.31
TP53 P04637 1/20 0.31
CA1 P00915 2/20 0.30
CA12 O43570 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086642 0.91
SCHEMBL1079287 0.85 PHGDH (0.31) ALDH1A1ALDH2MGLLTP53
SCHEMBL7952884 0.75 PHGDH (0.31) ALDH1A1ALDH2MGLLTP53
SCHEMBL1096599 0.73
SCHEMBL21106637 0.70
SCHEMBL9195897 0.69
SCHEMBL6996893 0.66 GPR84 (0.47) ALDH1A1TP53
SCHEMBL11399453 0.65 PHGDH (0.31) ALDH1A1ALDH2MGLLTP53
SCHEMBL5747742 0.65
SCHEMBL12288885 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0725637-B1 PARENTERAL BUSULFAN FOR TREATMENT OF MALIGNANT DISEASE UNIV TEXAS (US) 2000-11-22 EP disclosed
US-5559148-A Parenteral busulfan for treatment of malignant disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1996-09-24 US disclosed
EP-0725637-A1 PARENTERAL BUSULFAN FOR TREATMENT OF MALIGNANT DISEASE THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1996-08-14 EP disclosed
US-5430057-A Aqueous mixture with solvent; anticarcinogenic agents; leukemia, lymphoma BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-07-04 US disclosed
WO-1995008991-A1 PARENTERAL BUSULFAN FOR TREATMENT OF MALIGNANT DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-04-06 WO disclosed